AD Pharma

Global Drugs for Schistosomiasis Market (Praziquantel, Oxamniquine and Other) Industry Development Trend and Key Manufacturers Analysis 2017-2022 : Global QYResearch

Press Release   •   Feb 16, 2017 12:57 EET

The Global Drugs for Schistosomiasis Market 2016 is a professional and in-depth study on the current state of the Drugs for Schistosomiasis market. Annual estimates and forecasts are provided for the period 2015 through 2021. Also, a six-year historic analysis is provided for these markets. The global market for Drugs for Schistosomiasis is expected to reach about 1700 million units by 2021 from 1200 million units in 2016, registering a compounded annual growth rate (CAGR) of 7.6% during the analysis period, 2016-2021.

This report studies Global Drugs for Schistosomiasis Market 2017, especially in West Africa, East Africa, Latin America, Middle East, Southeast Asia, Rest of Asia, etc. focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals

Market segment by regions, this report splits global into several key regions, with production, consumption, revenue, and market share and growth rate of Drugs for Schistosomiasis in these regions, from 2011 to 2021 (forecast), like

West Africa
East Africa
Latin America
Middle East
Southeast Asia
Rest of Asia
Other

Request more information at http://globalqyresearch.com/download-sample/164781

Split by product types, with production, revenue, price, and market share and growth rate of each type, can be divided into
Praziquantel
Oxamniquine
Other

Split application, this report focuses on consumption, market share and growth rate of Drugs for Schistosomiasis in each application, can be divided into
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market

View full report at http://globalqyresearch.com/global-drugs-for-schistosomiasis-market-professional-survey-report-2017

Table of Contents

1 Industry Overview of Drugs for Schistosomiasis 1
1.1 Definition and Specifications of Drugs for Schistosomiasis 1
1.1.1 Definition of Drugs for Schistosomiasis 1
1.1.2 Specifications of Drugs for Schistosomiasis 2
1.2 Classification of Drugs for Schistosomiasis 3
1.2.1 Praziquantel 4
1.2.2 Oxamniquine 5
1.3 Applications of Drugs for Schistosomiasis 5
1.4 Market Segment by Regions 7
1.4.1 West Africa 8
1.4.2 East Africa 8
1.4.3 Latin America 9
1.4.4 Middle East 10
1.4.5 Southeast Asia 10
1.4.6 Rest of Asia 11
2 Manufacturing Cost Structure Analysis of Drugs for Schistosomiasis 12
2.1 Raw Material and Suppliers 12
2.2 Manufacturing Cost Structure Analysis of Drugs for Schistosomiasis 12
2.3 Manufacturing Process Analysis of Drugs for Schistosomiasis 13
2.4 Industry Chain Structure of Drugs for Schistosomiasis 14
2.5 Labor Cost of Drugs for Schistosomiasis 14
2.5.1 USA Labor Cost Analysis 15
2.5.2 Latin America Labor Costs Analysis 17
2.5.3 Asia Labor Costs Analysis 19
2.6 Other Costs Analysis 21
2.6.1 USA Other Cost Analysis 21
2.6.2 Latin America Other Cost Analysis 22
2.6.3 East Africa Other Cost Analysis 23
3 Technical Data and Manufacturing Plants Analysis of Drugs for Schistosomiasis 26
3.1 Capacity and Founded Date of Global Drugs for Schistosomiasis Major Manufacturers in 2015 26
3.2 Headquarter of Global Drugs for Schistosomiasis Major Manufacturers in 2015 26
3.3 New Technology of Global Drugs for Schistosomiasis 27
3.4 Products Brand of Global Drugs for Schistosomiasis Major Manufacturers in 2015 27
4 Global Drugs for Schistosomiasis Overall Market Overview 28
4.1 2011-2016E Overall Market Analysis 28
4.2 Capacity Analysis 29
4.2.1 2011-2016E Global Drugs for Schistosomiasis Capacity and Growth Rate Analysis 29
4.2.2 2015 Drugs for Schistosomiasis Capacity Analysis (Company Segment) 30
4.3 Sales Analysis 31
4.3.1 2011-2016E Global Drugs for Schistosomiasis Sales and Growth Rate Analysis 31
4.3.2 2015 Drugs for Schistosomiasis Sales Analysis (Company Segment) 31
4.4 Price Analysis 32
4.4.1 2011-2016E Global Drugs for Schistosomiasis Price 32
4.4.2 2015 Drugs for Schistosomiasis Price Analysis (Company Segment) 32
4.5 Drugs for Schistosomiasis Sales and Sales Revenue Analysis by Region 33
4.5.1 Drugs for Schistosomiasis Sales Analysis by Region 33
4.5.2 Drugs for Schistosomiasis Sales Revenue Analysis by Region 37
5 Drugs for Schistosomiasis Regional Market Analysis 41
5.1 West Africa Drugs for Schistosomiasis Market Analysis 41
5.1.1 West Africa Drugs for Schistosomiasis Market Overview 41
5.1.2 West Africa 2011-2016E Drugs for Schistosomiasis Local Supply, Import, Export, Local Consumption Analysis 41
5.1.3 West Africa 2011-2016E Drugs for Schistosomiasis Sales Price Analysis 42
5.1.4 West Africa 2015 Drugs for Schistosomiasis Market Share Analysis 43
5.2 East Africa Drugs for Schistosomiasis Market Analysis 43
5.2.1 East Africa Drugs for Schistosomiasis Market Overview 43
5.2.2 East Africa 2011-2016E Drugs for Schistosomiasis Local Supply, Import, Export, Local Consumption Analysis 44
5.2.3 East Africa 2011-2016E Drugs for Schistosomiasis Sales Price Analysis 44
5.2.4 East Africa 2015 Drugs for Schistosomiasis Market Share Analysis 45
5.3 Latin America Drugs for Schistosomiasis Market Analysis 45
5.3.1 Latin America Drugs for Schistosomiasis Market Overview 45
5.3.2 Latin America 2011-2016E Drugs for Schistosomiasis Local Supply, Import, Export, Local Consumption Analysis 46
5.3.3 Latin America 2011-2016E Drugs for Schistosomiasis Sales Price Analysis 46
5.3.4 Latin America 2015 Drugs for Schistosomiasis Market Share Analysis 47
5.4 Middle East Drugs for Schistosomiasis Market Analysis 48
5.4.1 Middle East Drugs for Schistosomiasis Market Overview 48
5.4.2 Middle East 2011-2016E Drugs for Schistosomiasis Local Supply, Import, Export, Local Consumption Analysis 48
5.4.3 Middle East 2011-2016E Drugs for Schistosomiasis Sales Price Analysis 49
5.4.4 Middle East 2015 Drugs for Schistosomiasis Market Share Analysis 50
5.5 Southeast Asia Drugs for Schistosomiasis Market Analysis 50
5.5.1 Southeast Asia Drugs for Schistosomiasis Market Overview 50
5.5.2 Southeast Asia 2011-2016E Drugs for Schistosomiasis Local Supply, Import, Export, Local Consumption Analysis 51
5.5.3 Southeast Asia 2011-2016E Drugs for Schistosomiasis Sales Price Analysis 51
5.5.4 Southeast Asia 2015 Drugs for Schistosomiasis Market Share Analysis 52
5.6 Rest of Asia Drugs for Schistosomiasis Market Analysis 53
5.6.1 Rest of Asia Drugs for Schistosomiasis Market Overview 53
5.6.2 Rest of Asia 2011-2016E Drugs for Schistosomiasis Local Supply, Import, Export, Local Consumption Analysis 53
5.6.3 Rest of Asia 2011-2016E Drugs for Schistosomiasis Sales Price Analysis 54
5.6.4 Rest of Asia 2015 Drugs for Schistosomiasis Market Share Analysis 55
6 Global 2011-2016E Drugs for Schistosomiasis Segment Market Analysis (by Type) 56
6.1 Global 2011-2016E Drugs for Schistosomiasis Sales by Type 56
6.2 Different Types Drugs for Schistosomiasis Product Interview Price Analysis 58
6.3 Different Types Drugs for Schistosomiasis Product Growth Rate Analysis 58
6.3.1 Praziquantel Drugs for Schistosomiasis Sales and Growth Rate Analysis 58
6.3.2 Oxamniquine Drugs for Schistosomiasis Sales and Growth Rate Analysis 59
7 Global 2011-2016E Drugs for Schistosomiasis Segment Market Analysis (by Application) 60
7.1 Global 2011-2016E Drugs for Schistosomiasis Consumption by Application 60
7.2 Geographical Distribution of the Different Schistosomiasis Species 62
7.3 10 Facts about Schistosomiasis 62
8 Analysis of Drugs for Schistosomiasis Industry Key Manufacturers 64
8.1 Shin Poong 64
8.1.1 Company Profile 64
8.1.2 Product Information 65
8.1.3 Sales, Price and Revenue 65
8.1.4 Drugs for Schistosomiasis Business Region Distribution Analysis 66
8.2 Merck 66
8.2.1 Company Profile 66
8.2.2 Product Information 67
8.2.3 Sales, Price and Revenue 68
8.2.4 Drugs for Schistosomiasis Business Region Distribution Analysis 68
8.3 Bayer 69
8.3.1 Company Profile 69
8.3.2 Product Information 70
8.3.3 Sales, Price and Revenue 70
8.3.4 Drugs for Schistosomiasis Business Region Distribution Analysis 71
8.4 EIPICO 71
8.4.1 Company Profile 71
8.4.2 Product Information 72
8.4.3 Sales, Price and Revenue 73
8.4.4 Drugs for Schistosomiasis Business Region Distribution Analysis 73
8.5 Chandra Bhagat Pharma 74
8.5.1 Company Profile 74
8.5.2 Product Information 75
8.5.3 Sales, Price and Revenue 75
8.5.4 Drugs for Schistosomiasis Business Region Distribution Analysis 76
8.6 Taj Pharmaceuticals 76
8.6.1 Company Profile 76
8.6.2 Product Information 78
8.6.3 Sales, Price and Revenue 78
8.6.4 Drugs for Schistosomiasis Business Region Distribution Analysis 79
9 Development Trend of Analysis of Drugs for Schistosomiasis Market 80
9.1 Global Drugs for Schistosomiasis Market Trend Analysis 80
9.1.1 Global 2016-2021 Drugs for Schistosomiasis Market Size (Volume and Value) Forecast 80
9.1.2 Global 2016-2021 Drugs for Schistosomiasis Price Forecast 81
9.2 Drugs for Schistosomiasis Regional Market Trend 82
9.2.1 West Africa 2016-2021 Drugs for Schistosomiasis Consumption Forecast 82
9.2.2 East Africa 2016-2021 Drugs for Schistosomiasis Consumption Forecast 83
9.2.3 Latin America 2016-2021 Drugs for Schistosomiasis Consumption Forecast 84
9.2.4 Middle East 2016-2021 Drugs for Schistosomiasis Consumption Forecast 85
9.2.5 Southeast Asia 2016-2021 Drugs for Schistosomiasis Consumption Forecast 86
9.2.6 Rest of Asia 2016-2021 Drugs for Schistosomiasis Consumption Forecast 87
9.3 Drugs for Schistosomiasis Market Trend (Product Type) 87
9.4 Drugs for Schistosomiasis Market Trend (Application) 88
10 Drugs for Schistosomiasis Marketing Type Analysis 89
10.1 Drugs for Schistosomiasis Regional Marketing Type Analysis 89
10.2 Drugs for Schistosomiasis International Trade Type Analysis 91
10.3 Traders or Distributors with Contact Information of Drugs for Schistosomiasis 91
10.3.1 Distribution to Developing Countries 91
10.3.2 Distribution to Developed Countries 92
10.3.2 Bulk Suppliers for Developing Countries 92
10.4 Drugs for Schistosomiasis Supply Chain Analysis 93
11 Consumers Analysis of Drugs for Schistosomiasis 94
11.1 Data of Schistosomiasis about Some Countries in 2015 94
11.2 Essential Medicines Donated by Pharmaceutical Companies through WHO and Other Mechanisms 96
11.3 Mainly Countries or Regions Analysis of Schistosomiasis 100
11.3.1 Africa 100
11.3.2 Nigeria 101
11.3.3 Brazil 102
11.3.4 Central and South Asia 103
11.3.5 Democratic Republic of Congo 104
12 Conclusion of the Global Drugs for Schistosomiasis Market Professional Survey Report 2016 105
13 Appendix 106

To Purchase this premium Report With Complete TOC at http://globalqyresearch.com/checkout-form/0/164781

About Us:

Global QYResearch (http://globalqyresearch.com/ ) is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact Us:

Unit1, 26 Cleveland Road, South Woodford, London, E182AN, United Kingdom

Contact: +44 20 32392407

Email: sales@globalqyresearch.com

Follow us:https://www.linkedin.com/company/global-qy-research

Twitter: https://twitter.com/gqyresearch